Back to Insights

Continuation Breakout Monday 2PM 8/26/2024

August 26, 2024 3 min read

Overall Sector and Industry Analysis

Datetime Range Analyzed: 2024-07-27 to 2024-08-26 (EST)

Market Overview

The past month has shown mixed performances across various sectors and industries. Significant movements have been observed primarily in tech, biopharma, and consumer sectors based on the stocks analyzed.

Notable Sector Trends:

  1. Biopharma Sector:
    • Tickers: LLY, RMD, YMAB
    • Trends: Generally observed bullish momentum, especially for LLY and RMD, with significant volume spikes over the past 10 days. Innovations and positive earnings seem to fuel this trend.
  2. Tech Sector:
    • Tickers: MELI, CAN, BMBL, TEAM
    • Trends: Tech stocks have shown resilience amidst market volatility. MELI and CAN have shown consistent upward trends driven by strong sales performance and market expansion strategies. BMBL had a more mixed performance, potentially due to competition and market sentiment.
  3. Consumer Goods Sector:
    • Tickers: COST, CTAS
    • Trends: Both COST and CTAS have demonstrated steady growth with sporadic volume spikes indicating institutional interest.

Volume Analysis

  • A noticeable observation is that volume spikes have generally coincided with upward price actions, particularly for stocks such as CAN, LLY, and RMD. This indicates strong institutional accumulation.
  • Conversely, a few stocks like BMBL and KOSS have experienced volume spikes with limited upward price action indicating potential distribution zones.

Ticker Performance Prediction

Likely to Increase in the Next 2-3 Days

  1. LLY (Eli Lilly & Co.):
    • Prediction Basis: Strong consistent price rise with high volume. Strong fundamentals and sector performance.
  2. RMD (ResMed Inc.):
    • Prediction Basis: Positive momentum coupled with continuous buying signals over the past 10 days.
  3. YMAB (Y-mAbs Therapeutics):
    • Prediction Basis: Bullish candlestick patterns and strong volume support indicate further upward potential.
  4. CAN (Canaan Inc.):
    • Prediction Basis: Stable upwards movement with increasing volume indicative of strong institutional interest.
  5. CTAS (Cintas Corporation):
    • Prediction Basis: Continuous strong performance, solid support levels, and industry strength.

Individual Stock Analysis


LLY (Eli Lilly & Co.)

  • Support Levels:
    1. $948
    2. $940
    3. $930
  • Resistance Levels:
    1. $965
    2. $975
    3. $990
  • Price Action Prediction:
    • Next 2-3 Days: Expect continued upside towards the $965 level.
    • Price Targets:
    • Near-term: $965
    • Extension: $975
    • Entry Point: Near $948
    • Stop-Loss: Below $940
finviz dynamic chart for  LLY

RMD (ResMed Inc.)

  • Support Levels:
    1. $225
    2. $220
    3. $215
  • Resistance Levels:
    1. $230
    2. $235
    3. $240
  • Price Action Prediction:
    • Next 2-3 Days: Likely to move up to the $230 resistance level.
    • Price Targets:
    • Near-term: $230
    • Extension: $235
    • Entry Point: Near $225
    • Stop-Loss: Below $220
finviz dynamic chart for  RMD

YMAB (Y-mAbs Therapeutics)

  • Support Levels:
    1. $14.25
    2. $14.00
    3. $13.75
  • Resistance Levels:
    1. $14.75
    2. $15.00
    3. $15.50
  • Price Action Prediction:
    • Next 2-3 Days: Potential to reach towards $14.75.
    • Price Targets:
    • Near-term: $14.75
    • Extension: $15.00
    • Entry Point: Near $14.25
    • Stop-Loss: Below $14.00
finviz dynamic chart for  YMAB

CAN (Canaan Inc.)

  • Support Levels:
    1. $1.07
    2. $1.05
    3. $1.02
  • Resistance Levels:
    1. $1.10
    2. $1.15
    3. $1.20
  • Price Action Prediction:
    • Next 2-3 Days: Expect upside towards $1.10 resistance.
    • Price Targets:
    • Near-term: $1.10
    • Extension: $1.15
    • Entry Point: Near $1.07
    • Stop-Loss: Below $1.05
finviz dynamic chart for  CAN

CTAS (Cintas Corporation)

  • Support Levels:
    1. $792
    2. $788
    3. $783
  • Resistance Levels:
    1. $800
    2. $810
    3. $820
  • Price Action Prediction:
    • Next 2-3 Days: Momentum likely to push stock towards $800 level.
    • Price Targets:
    • Near-term: $800
    • Extension: $810
    • Entry Point: Near $792
    • Stop-Loss: Below $788
finviz dynamic chart for  CTAS

Conclusion:
The recent price and volume developments suggest that sectors such as biopharma and tech are experiencing significant bullish momentum, especially stocks like LLY, RMD, YMAB, CAN, and CTAS. These predictions leverage short-term momentum indicators, volume analysis, and key support and resistance levels to suggest potential trading opportunities.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Always perform your own due diligence before making any investment decisions.

Share: